El Oro Ltd (LON:ELX) insider E W. Houston purchased 25,000 shares of the businesss stock in a transaction on Friday, November 18th. The shares were purchased at an average price of GBX 67 ($0.84) per share, with a total value of …
"Colin and Neal together with Pedro will play a key role as we continue to advance our lead drug candidate, ELX-02, to …
ELX-02 is entering Phase 2 clinical development for Cystic Fibrosis ... and the quotation of the Company's common …
WAFB1mon
Emulex Corporation (NYSE: ELX), a leader in network connectivity ... Company's management based on its evaluation of market conditions, the trading price of the stock, the Company's cash needs, securities law limitations and other factors.
ELX-02 is entering Phase 2 clinical development for Cystic Fibrosis ... and the quotation of the Company's common …
WIS-TV1mon
Generally, when a momentum stock breaks down badly, it suffers bruises and broken ... http://investorplace.com/2012/11/second-chance-for-this-chip-maker-mlnx-qlgc-elx-brc/.
ELX-02 is entering Phase 2 clinical development for Cystic Fibrosis ... and the quotation of the Company's common stock on an over-the-counter securities market, as well as other factors expressed from time to time in the Company's …
The Director now holds 6,366,246 shares. Shares is the leading weekly publication for high net worth private investors and stock market professionals and as such is read weekly by thousands of private investors, analysts, fund managers, …
"Colin and Neal together with Pedro will play a key role as we continue to advance our lead drug candidate, ELX-02, to …
WBOC1mon